Analysts Set Addus HomeCare Co. (NASDAQ:ADUS) Target Price at $132.78

Shares of Addus HomeCare Co. (NASDAQ:ADUS) have been given a consensus recommendation of “Buy” by the ten analysts that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, seven have given a buy recommendation and two have issued a strong buy recommendation on the company. The average twelve-month target price among brokers that have covered the stock in the last year is $132.78.

A number of equities research analysts have recently weighed in on ADUS shares. Citizens Jmp raised Addus HomeCare to a “strong-buy” rating in a report on Monday, December 16th. Stephens reissued an “overweight” rating and set a $142.00 target price on shares of Addus HomeCare in a report on Wednesday, March 12th. Macquarie reissued an “outperform” rating and set a $129.00 target price on shares of Addus HomeCare in a report on Thursday, February 27th. JMP Securities started coverage on Addus HomeCare in a report on Monday, December 16th. They set an “outperform” rating and a $150.00 target price for the company. Finally, Oppenheimer lifted their target price on Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a report on Friday, January 24th.

Insider Buying and Selling

In other Addus HomeCare news, CEO R Dirk Allison sold 25,000 shares of Addus HomeCare stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the transaction, the chief executive officer now owns 79,397 shares in the company, valued at $9,905,569.72. The trade was a 23.95 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 4.60% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Armis Advisers LLC bought a new position in Addus HomeCare in the fourth quarter valued at about $295,000. Integrated Advisors Network LLC grew its position in Addus HomeCare by 8.5% in the fourth quarter. Integrated Advisors Network LLC now owns 4,261 shares of the company’s stock valued at $534,000 after acquiring an additional 333 shares during the last quarter. Public Employees Retirement System of Ohio acquired a new stake in shares of Addus HomeCare during the fourth quarter valued at about $4,985,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of Addus HomeCare by 43.7% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 48,727 shares of the company’s stock valued at $6,108,000 after purchasing an additional 14,812 shares in the last quarter. Finally, Squarepoint Ops LLC acquired a new stake in shares of Addus HomeCare during the fourth quarter valued at about $389,000. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Price Performance

Shares of Addus HomeCare stock opened at $89.83 on Monday. The business has a fifty day simple moving average of $111.83 and a two-hundred day simple moving average of $121.87. Addus HomeCare has a 1 year low of $87.88 and a 1 year high of $136.72. The company has a market capitalization of $1.63 billion, a price-to-earnings ratio of 20.56, a P/E/G ratio of 1.41 and a beta of 0.97.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, February 24th. The company reported $1.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.35 by ($0.09). Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The business had revenue of $297.14 million for the quarter, compared to analyst estimates of $291.04 million. As a group, equities analysts anticipate that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.